AI Article Synopsis
- Posterior reversible encephalopathy syndrome (PRES) is a condition with symptoms like headaches, seizures, and altered mental status, often visible on brain MRI.
- The exact cause of PRES remains unclear.
- A case study highlights a 27-year-old woman who experienced PRES following FOLFOX 5 chemotherapy for colorectal cancer.
Article Abstract
Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600224 | PMC |
| http://dx.doi.org/10.1155/2013/306983 | DOI Listing |
Publication Analysis
Top Keywords
posterior reversible
8
reversible encephalopathy
8
encephalopathy syndrome
8
syndrome associated
4
associated folfox
4
folfox chemotherapy
4
chemotherapy posterior
4
syndrome pres
4
pres clinicoradiologic
4
clinicoradiologic entity
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!